LOBBYIST

Mark Epley

Registrant in 2026 disclosures: Arnold & Porter Kaye Scholer LLP

← Back to lobbyists

Following Mark Epley’s registrations? Leave your email and we’ll follow up personally when their filings change.

32ACTIVITIES
2DISCLOSED CLIENTS
0BILLS

Disclosed clients

2

Clients named in filings listing Mark, across all filing years. Activity counts are disclosure mentions, not a list of current engagements.

Novo Nordisk, Inc.24 activities
Grand Canyon University8 activities

Limited preview · paid intelligence

Keep the intelligence current—not just this one record.

Unlock the full client and employer history, complete bill and issue activity, inferred contact intelligence, and the joined map of where this lobbyist appears across the Pulse database.

Full records and recurring monitoring are paid. A work email or free alert subscription does not unlock them. Request coverage for your team; a walkthrough is optional.

Request Paid Coverage for Your TeamPrefer a walkthrough first?Already a customer? Sign inGet free intelligence alerts →

Source filing samples

Most recent available disclosure for each client shown above. Consult the original filing to verify context; these samples are not the complete filing history.

Novo Nordisk, Inc. · 2026 first_quarter filing ↗

Grand Canyon University · 2026 first_quarter filing ↗

Issue mix

LDA general-issue codes weighted by activity count.

Pharmacy8
Health Issues8
Consumer Issues/Safety/Products8

+ 1 more issue areas in the full intelligence view

Is this you? Claim or correct this profile.